181 related articles for article (PubMed ID: 34111938)
1. Of Mice and Schoolchildren: A Conceptual History of Herd Immunity.
Robertson D
Am J Public Health; 2021 Aug; 111(8):1473-1480. PubMed ID: 34111938
[TBL] [Abstract][Full Text] [Related]
2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
3. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
Chun JY; Jeong H; Kim Y
J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
[TBL] [Abstract][Full Text] [Related]
4. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
Chen JM; Sun YX; Chen JW
J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
[TBL] [Abstract][Full Text] [Related]
5. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
6. Will vaccination refusal prolong the war on SARS-CoV-2?
Marcec R; Majta M; Likic R
Postgrad Med J; 2021 Mar; 97(1145):143-149. PubMed ID: 33115909
[TBL] [Abstract][Full Text] [Related]
7. Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination.
Shin DH; Oh HS; Jang H; Lee S; Choi BS; Kim D
J Korean Med Sci; 2022 Jan; 37(3):e23. PubMed ID: 35040298
[TBL] [Abstract][Full Text] [Related]
8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
9. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
She J; Hou D; Chen C; Bi J; Song Y
Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
[TBL] [Abstract][Full Text] [Related]
10. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
McDermott A
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
[No Abstract] [Full Text] [Related]
11. Herd immunity to endemic diseases: Historical concepts and implications for public health policy.
Robertson D; Heriot G; Jamrozik E
J Eval Clin Pract; 2024 Jun; 30(4):625-631. PubMed ID: 38562003
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity.
Bao P; Gong J; Mu M; Que Y; Hu P; Luo J; Chang C; Xu G
Chin Med J (Engl); 2023 Jul; 136(13):1627-1629. PubMed ID: 36806245
[No Abstract] [Full Text] [Related]
13. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
[TBL] [Abstract][Full Text] [Related]
14. A Blueprint to Control the SARS-CoV-2 Pandemic.
O'Horo JC; Williams AW; Badley AD
Mayo Clin Proc; 2021 May; 96(5):1128-1131. PubMed ID: 33958050
[No Abstract] [Full Text] [Related]
15. The long road.
Cohen J
Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
[No Abstract] [Full Text] [Related]
16. Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
Mukherjee S; Ray SK
Infect Disord Drug Targets; 2022; 22(4):e170122200309. PubMed ID: 35040409
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
Wong RSY
Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide.
Hussain H; Ganesh A; Milane L; Amiji M
Expert Opin Drug Deliv; 2023 Apr; 20(4):489-506. PubMed ID: 36890642
[TBL] [Abstract][Full Text] [Related]
19. Herd Immunity Against Coronavirus: A Review.
Datta S; Roy A
Recent Pat Biotechnol; 2022 Aug; 16(3):256-265. PubMed ID: 35400332
[TBL] [Abstract][Full Text] [Related]
20. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
